已入深夜,您辛苦了!由于当前在线用户较少,发布求助请尽量完整地填写文献信息,科研通机器人24小时在线,伴您度过漫漫科研夜!祝你早点完成任务,早点休息,好梦!

Xietu Hemu Prescription Improves Metabolic Dysfunction-Associated Steatotic Liver Disease: A Real-World Cohort Study

医学 药方 队列 疾病 生物信息学 内科学 重症监护医学 药理学 生物
作者
Liu-lan Xiang,Yu-tian Cao,Xiaoxiao Wang,Gaoxiang Wang,Yujuan Zhang,Ruihan Li,Fang Qi,Jiaxuan Huai,Jing Ping Sun,Xiaojin He,Xiqiao Zhou
出处
期刊:Journal of multidisciplinary healthcare [Dove Medical Press]
卷期号:Volume 18: 4377-4389 被引量:1
标识
DOI:10.2147/jmdh.s522519
摘要

Purpose: This study aims to evaluate the efficacy of the Xietu Hemu prescription (XHP) in improving metabolic dysfunction-associated steatotic liver disease (MASLD) through a Real World Study approach. Methods: This was a single-center, prospective, real-world cohort study of 262 patients with MASLD who met the inclusion and exclusion criteria from November 2021 to November 2023 at Jiangsu Provincial Hospital of Traditional Chinese Medicine. The exposure of this study was who took the XHP. We assessed the efficacy of the XHP on MASLD by comparing FibroScan parameters, body composition indicators, and liver serological indicators. The XHP was then evaluated for MASLD by inverse probability of treatment weighting (IPTW) as well as log-binomial analysis. Results: We ended up collecting the exposure cohort (n=163) and the referent cohort (n=99). Patients were categorized into an exposure cohort (n=163, XHP + basic treatment) subdivided by treatment duration: 4 weeks (n=28), 8 weeks (n=60), 12 weeks (n=51), and ≥16 weeks (n=24), and a referent cohort (n=99, basic treatment alone). The results showed significant improvements in Liver stiffness measurement (LSM), controlled attenuation parameter (CAP), body mass index (BMI), waist-to-hip ratio (WHR), visceral fat area (VFA), the fatty liver index (FLI), and FibroScan-AST (FAST) in the exposure cohort after treatment compared to before treatment. After controlling confounding by IPTW, log-binomial analysis revealed that XHP administration was significantly more effective for MASLD in the exposure cohort than in the referent cohort (weighted risk ratio=2.99, 95% CI=1.86 to 4.89, p<0.001). Subgroup analyses revealed a significantly greater efficacy of the XHP in the exposure cohort compared to the MASLD referent cohort, across various durations and dosages of XHP and varying degrees of hepatic steatosis and fibrosis. No serious adverse events occurred; occasional mild gastrointestinal reactions were self-limiting. Conclusion: The results of our study suggest that XHP has a significant treatment effect on MASLD, which hopes to complement the current lack of treatment for MASLD.
最长约 10秒,即可获得该文献文件

科研通智能强力驱动
Strongly Powered by AbleSci AI
科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
1秒前
yufu发布了新的文献求助50
3秒前
3秒前
黄jw完成签到 ,获得积分10
4秒前
文艺的早晨完成签到 ,获得积分10
5秒前
研友_VZG7GZ的应助被小玲子采纳,获得10
6秒前
AccompanyX发布了新的文献求助10
8秒前
爱笑楼房完成签到,获得积分10
8秒前
所所的应助被冷酷的水壶采纳,获得10
9秒前
Hoda的应助被automan采纳,获得10
9秒前
bkagyin的应助被嗦了一碗粉采纳,获得10
9秒前
一一完成签到 ,获得积分10
9秒前
10秒前
有病早治完成签到 ,获得积分10
10秒前
chiyudawang发布了新的文献求助10
11秒前
11秒前
情怀的应助被wonderfulwisdom采纳,获得10
11秒前
11秒前
时间完成签到,获得积分10
12秒前
喻喻喻同志完成签到 ,获得积分10
14秒前
15秒前
15秒前
风吹麦浪的应助被Gibson采纳,获得10
15秒前
16秒前
leegawei发布了新的文献求助10
16秒前
Akim的应助被rain采纳,获得10
17秒前
yangx完成签到,获得积分10
18秒前
英姑的应助被秃头泡泡采纳,获得10
18秒前
19秒前
123发布了新的文献求助10
19秒前
三岁半完成签到 ,获得积分10
20秒前
江就的应助被why采纳,获得10
20秒前
20秒前
20秒前
嗦了一碗粉完成签到,获得积分10
21秒前
英俊的铭的应助被dd采纳,获得10
22秒前
朴素的尔蝶完成签到 ,获得积分10
22秒前
22秒前
小马甲的应助被whz采纳,获得10
23秒前
23秒前
高分求助中
(应助此贴封号)【重要!!请各用户(尤其是新用户)详细阅读】【科研通的精品贴汇总】 10000
拉伸高分子熔体中缠结行为的模拟和小角中子散射研究 1700
Grapes 1000
The World Atlas of Wine 9th edition 1000
奈特基础组织学:配套组织病理学(第4版)(Netter's Essential Histology With Correlated Histopathology) 800
John McDowells Bildungstheorie 800
八旗制度の研究 600
热门求助领域 (近24小时)
化学 材料科学 医学 生物 纳米技术 计算机科学 工程类 有机化学 化学工程 生物化学 物理 复合材料 内科学 催化作用 光电子学 人工智能 细胞生物学 无机化学 物理化学 数学
热门帖子
关注 科研通微信公众号,转发送积分 8179198
求助须知:如何正确求助?哪些是违规求助? 9569781
关于积分的说明 21806509
捐赠科研通 7774542
什么是DOI,文献DOI怎么找? 3433008
关于科研通互助平台的介绍 2556929
邀请新用户注册赠送积分活动 2478652